Citadel Advisors’s Octave Specialty Group OSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $352K | Sell |
75,600
-1,252,400
| -94% | -$7.17M | ﹤0.01% | 10115 |
|
|
2025
Q4 | $10.3M | Buy |
1,328,000
+297,100
| +29% | +$2.54M | ﹤0.01% | 3215 |
|
|
2025
Q3 | $8.6M | Buy |
1,030,900
+873,200
| +554% | +$7.38M | ﹤0.01% | 3489 |
|
|
2025
Q2 | $1.12M | Sell |
157,700
-137,100
| -47% | -$1.02M | ﹤0.01% | 6845 |
|
|
2025
Q1 | $2.58M | Buy |
294,800
+68,500
| +30% | +$721K | ﹤0.01% | 5044 |
|
|
2024
Q4 | $2.86M | Sell |
226,300
-37,300
| -14% | -$450K | ﹤0.01% | 4919 |
|
|
2024
Q3 | $2.95M | Buy |
263,600
+143,300
| +119% | +$1.68M | ﹤0.01% | 4811 |
|
|
2024
Q2 | $1.54M | Sell |
120,300
-27,600
| -19% | -$421K | ﹤0.01% | 5795 |
|
|
2024
Q1 | $2.31M | Sell |
147,900
-19,900
| -12% | -$314K | ﹤0.01% | 5240 |
|
|
2023
Q4 | $2.77M | Buy |
167,800
+101,200
| +152% | +$1.41M | ﹤0.01% | 4791 |
|
|
2023
Q3 | $803K | Buy |
66,600
+23,400
| +54% | +$314K | ﹤0.01% | 7029 |
|
|
2023
Q2 | $615K | Sell |
43,200
-131,500
| -75% | -$1.92M | ﹤0.01% | 7478 |
|
|
2023
Q1 | $2.7M | Buy |
174,700
+69,700
| +66% | +$1.13M | ﹤0.01% | 4810 |
|
|
2022
Q4 | $1.83M | Sell |
105,000
-309,800
| -75% | -$4.6M | ﹤0.01% | 5642 |
|
|
2022
Q3 | $5.29M | Buy |
414,800
+325,500
| +365% | +$4.34M | ﹤0.01% | 3765 |
|
|
2022
Q2 | $1.01M | Sell |
89,300
-188,200
| -68% | -$1.79M | ﹤0.01% | 6987 |
|
|
2022
Q1 | $2.89M | Buy |
277,500
+168,400
| +154% | +$2.28M | ﹤0.01% | 5283 |
|
|
2021
Q4 | $1.75M | Buy |
109,100
+48,300
| +79% | +$759K | ﹤0.01% | 6555 |
|
|
2021
Q3 | $871K | Buy |
60,800
+3,200
| +6% | +$45.7K | ﹤0.01% | 8493 |
|
|
2021
Q2 | $902K | Buy |
57,600
+8,100
| +16% | +$130K | ﹤0.01% | 8623 |
|
|
2021
Q1 | $829K | Sell |
49,500
-3,600
| -7% | -$58.8K | ﹤0.01% | 8563 |
|
|
2020
Q4 | $817K | Buy |
53,100
+4,100
| +8% | +$60.4K | ﹤0.01% | 7216 |
|
|
2020
Q3 | $626K | Sell |
49,000
-97,900
| -67% | -$1.26M | ﹤0.01% | 6877 |
|
|
2020
Q2 | $2.1M | Sell |
146,900
-76,700
| -34% | -$1.12M | ﹤0.01% | 4481 |
|
|
2020
Q1 | $2.76M | Buy |
223,600
+168,300
| +304% | +$3.23M | ﹤0.01% | 3603 |
|
|
2019
Q4 | $1.19M | Sell |
55,300
-17,600
| -24% | -$361K | ﹤0.01% | 5279 |
|
|
2019
Q3 | $1.43M | Sell |
72,900
-1,276,800
| -95% | -$23.4M | ﹤0.01% | 5012 |
|
|
2019
Q2 | $22.7M | Buy |
1,349,700
+901,500
| +201% | +$15.4M | 0.01% | 1309 |
|
|
2019
Q1 | $8.12M | Buy |
448,200
+369,900
| +472% | +$7.07M | ﹤0.01% | 2321 |
|
|
2018
Q4 | $1.35M | Buy |
78,300
+8,200
| +12% | +$151K | ﹤0.01% | 4804 |
|
|
2018
Q3 | $1.43M | Buy |
70,100
+22,400
| +47% | +$468K | ﹤0.01% | 4937 |
|
|
2018
Q2 | $947K | Buy |
47,700
+18,200
| +62% | +$336K | ﹤0.01% | 5316 |
|
|
2018
Q1 | $463K | Buy |
+29,500
| New | +$456K | ﹤0.01% | 6005 |
|
|
2017
Q4 | – | Sell |
-11,200
| Closed | -$193K | – | 7920 |
|
|
2017
Q3 | $193K | Buy |
11,200
+100
| +0.9% | +$1.85K | ﹤0.01% | 6725 |
|
|
2017
Q2 | $193K | Sell |
11,100
-40,100
| -78% | -$712K | ﹤0.01% | 6598 |
|
|
2017
Q1 | $966K | Buy |
51,200
+26,200
| +105% | +$551K | ﹤0.01% | 4048 |
|
|
2016
Q4 | $563K | Buy |
25,000
+12,400
| +98% | +$271K | ﹤0.01% | 4715 |
|
|
2016
Q3 | $232K | Buy |
+12,600
| New | +$226K | ﹤0.01% | 6094 |
|
Other funds holding OSG
WSL
VCM
PGCM
WHCM
GJL
TAM
BCC
Citadel Advisors's OSG Position: Q1 2026 in Review
Citadel Advisors increased its Octave Specialty Group (OSG) stake by 50% in Q1 2026, buying an estimated $827K and bringing the position to 431,809 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #6057.
Citadel Advisors first reported a position in OSG in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.65M in Q1 2025. 148 funds tracked by Wall St. Rank hold OSG as of Q1 2026.
- Citadel Advisors held 431,809 shares of Octave Specialty Group worth $2.01M as of Q1 2026.
- Citadel Advisors bought 144,526 Octave Specialty Group shares in Q1 2026, an estimated $827K.
- Octave Specialty Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6057 holding.
- Citadel Advisors first reported a position in Octave Specialty Group in Q2 2013 and has held it in 48 quarters since.
- Citadel Advisors's Octave Specialty Group position peaked at $9.65M in Q1 2025.
- 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.